Regentis Biomaterials Ltd (RGNT) insider trading
Every open-market stock purchase and sale by Regentis Biomaterials Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.40 on Oct 22, 2026.
Recent RGNT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 9, 2026 | Susan Alpert PHD MD (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Pini Ben-Elazar (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Pini Ben-Elazar (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Keith Valentine (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Jeff Dykan (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Jeff Dykan (Director) | Bought (not open market) | — |
| Jul 9, 2026 | Ehud Geller (CEO) | Bought (not open market) | — |
| Jul 9, 2026 | Efraim Cohen-Arazi (Director) | Bought (not open market) | — |
Who's trading RGNT
- Susan Alpert PHD MD, Director: other filings, last Jul 9, 2026
- Pini Ben-Elazar, Director: other filings, last Jul 9, 2026
- Efraim Cohen-Arazi, Director: other filings, last Jul 9, 2026
- Jeff Dykan, Director: other filings, last Jul 9, 2026
- Ehud Geller, CEO: other filings, last Jul 9, 2026
- Keith Valentine, Director: other filings, last Jul 9, 2026
Get free alerts when an insider at Regentis Biomaterials Ltd files a new trade →